• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Sytrue, HighFive Partner to Optimize Medication Reconciliation for Providers

by HITC Staff 12/17/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

SyTrue

SyTrue, Inc., a healthcare data-refinement company, that specializes in natural language processing (NLP) solutions used to translate unstructured medical data into useable clinical information, announced today, a partnership with HighFive, who provides community wide medication management solutions.

Partnership Details

Leveraging SyTrue’s NLP OS™ and Semantic terminology server, HighFive has normalized medication data from free text as well as disparate systems into usable interoperable data with assigned RXNORM codes, enabling more robust medication reconciliation and optimization. SyTrue’s terminology server extracts text from any provided medical documents and immediately converts it into the associated RXNORM code.

This solution provides distinct advantages to HighFive customers by providing efficiencies and improved quality.  It eliminates the time-consuming step of manually mapping data, thus significantly reducing implementation costs and timeline. SyTrue’s technology enables HighFive to deploy community-wide medication management networks of primary care and specialist practices, free clinics, retail pharmacies, hospitals, behavioral health clinics and skilled nursing facilities in a fraction of the time (and cost) it would take if done any other way.

Strong medication reconciliation and optimization improves adherence

Numerous studies have identified that adverse medication events are at the very core of the readmission problem. This includes patient non-adherence to prescribed drug therapy, which by itself leads to treatment failures and wasted resources costing $150 billion annually. HighFive is now able to provide all healthcare providers and information systems more complete, reconciled medication lists to base care plans around and ultimately improve quality and outcomes.

When a pharmacist has the ability to communicate a richer medication use story including the medication lists from all the patient providers along with medication fill history, better patient care is inevitable. Strong medication reconciliation and optimization improves adherence, outcomes and reduces readmissions and adverse drug events. 

“We’re thankful SyTrue has both the expertise and the foresight to produce such catalytic technology to advance the care of populations and community wide medication management. Due to SyTrue, HighFive customer’s can reduce readmissions and unplanned hospitalizations at a justifiable cost.”  – Keith Streckenbach, CEO of HighFive

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Sytrue

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |